6 studies found for:    LCI699
Show Display Options
Rank Status Study
1 Not yet recruiting Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: LCI699
2 Recruiting Safety and Efficacy of LCI699 in Cushing's Disease Patients.
Condition: Cushing's Disease
Intervention: Drug: LCI699
3 Completed An Evaluation of the Effects of LCI699 on Cortisol in Patients With Hypertension
Condition: Hypertension
Interventions: Drug: Placebo;   Drug: LCI699
4 Completed A Study to Evaluate the Effects of LCI699 on Safety and Efficacy in Subjects With Resistant Hypertension Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic
Condition: Hypertension
Interventions: Drug: LCI699;   Drug: Placebo;   Drug: Eplerenone
5 Completed A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Finding Study to Evaluate the Efficacy and Safety of LCI699, a New Experimental Antihypertensive Drug, in Patients With Essential Hypertension
Condition: Essential Hypertension
Interventions: Drug: LCI699;   Drug: Eplerenone;   Drug: Placebo
6 Completed Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism
Condition: Primary Hyperaldosteronism
Intervention: Drug: LCI699

Indicates status has not been verified in more than two years